Skip to main content
SpringerLink
Log in

Pharmacological activity of Salvinorin A, the major component of Salvia divinorum

  • Review
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

The hallucinogenic plant Salvia divinorum (i.e., “magic mint”) is a member of the Sage family that has been historically used for divination and shamanism by the Mazatecs. Today, S. divinorum has become increasingly popular as a recreational drug for its hallucinogenic effects. The non-nitrogenous diterpene, salvinorin A, the major active component of S. divinorum, is responsible for the hallucinogenic effect of this plant. Here, we described the behavioral effects of salvinorin A in animals including the addictive, antinociception and antidepressant properties of the drug. The present paper also demonstrates the not well recognized (or unclear) mechanisms of action of salvinorin A. The last part of the paper presents information about the legal status of S. divinorum and its derivatives. Taking into account the increasing popularity and consumption of salvinorin A and S. divinorum today, it is important to collect all data on the pharmacological profile of this plant and its products.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker LE, Panos JJ, Killinger BA, Peet MM, Bell LM, Haliw LA, Walker SL: Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69, 593 and U50, 488 in rats. Psychopharmacology, 2009, 203, 203–211.

    Article  CAS  Google Scholar 

  2. Braida D, Capurro V, Zani A, Rubino T, Viganò D, Paro-laro D, Sala M: Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol, 2009, 157, 844–853.

    Article  CAS  Google Scholar 

  3. Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A et al.: Involvement of K-opioid and en-docannabinoid system on Salvinorin A-induced reward. Biol Psychiatry, 2008, 63, 286–292.

    Article  CAS  Google Scholar 

  4. Butelman ER, Rus S, Prisinzano TE, Kreek MJ: The discriminative effects of the K-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects. Psychopharmacology, 2010, 210, 253–262.

    Article  CAS  Google Scholar 

  5. Chavkin C, Sud S, Jin W, Stewart J, Zjawiony JK, Siebert DJ, Toth BA et al.: Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious K-opioid receptor agonist: structural and functional considerations. J Pharmacol Exp Ther, 2004, 308, 1197–1203.

    Article  CAS  Google Scholar 

  6. Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH: Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accum-bens. Psychopharmacology, 2010, 210, 241–252.

    Article  CAS  Google Scholar 

  7. Fichna J, Schicho R, Janecka A, Zjawiony JK, Storr M: Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction. Drug News Perspect, 2009, 22, 383–392.

    Article  CAS  Google Scholar 

  8. Gehrke BJ, Chefer VI, Shippenberg TS: Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology, 2008, 197, 509–517.

    Article  CAS  Google Scholar 

  9. González D, Riba J, Bouso JC, Gómez-Jarabo G, Barba-noj MJ: Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug Alcohol Depend, 2006, 85, 157–162.

    Article  Google Scholar 

  10. Halpern JH: Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther, 2004, 102, 131–138.

    Article  CAS  Google Scholar 

  11. Hanes KR: Antidepressant effects of the herb Salvia divinorum: a case report. J Clin Psychopharmacol, 2001, 21, 634–635.

    Article  CAS  Google Scholar 

  12. https://doi.org/www.sagewisdom.prg/legalstatus.html.

  13. McCurdy CR, Sufka KJ, Smith GH, Warnick JE, Nieto MJ: Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist. Pharmacol Biochem Behav, 2006, 83, 109–113.

    Article  CAS  Google Scholar 

  14. Nemeth CL, Paine TA, Rittiner JE, Béguin C, Carroll FI, Roth BL, Cohen BM, Carlezon WA Jr: Role of kappa-opioid receptors in the effects of salvinorin A and keta-mine on attention in rats. Psychopharmacology, 2010, 210, 263–274.

    Article  CAS  Google Scholar 

  15. Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P et al.: Salvinorin A: a potent naturally occurring nonnitrogenous K opioid selective agonist. Proc Natl Acad Sci USA, 2002, 99, 11934–11939.

    Article  CAS  Google Scholar 

  16. Roth BL, Lopez E, Beische, S, Evans JM: Screening the receptorome to discover molecular targets responsible for plant-derived psychoactive compounds: a novel approach for CNS drug discovery. Pharmacol Ther, 2004, 102, 99–110.

    Article  CAS  Google Scholar 

  17. Seeman P, Guan HC, Hirbec H: Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse, 2009, 63, 698–704.

    Article  CAS  Google Scholar 

  18. Siebert DJ: Salvia divinorum and salvinorin A: new pharmacologic findings. J Ethnopharmacol, 1994, 43, 53–56.

    Article  CAS  Google Scholar 

  19. Valdés LJ: Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A: J Psychoactive Drugs, 1994, 26, 277–283.

    PubMed  Google Scholar 

  20. Valdés LJ, Díaz JL, Paul AG: Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.). J Ethnopharmacol, 1983, 7, 287–312.

    Article  Google Scholar 

  21. Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE Jr et al.: Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology, 2010, 210, 275–284.

    Article  CAS  Google Scholar 

  22. Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH: The hallucinogen derived from Salvia divinorum, salvinorin A, has K-opioid agonist discriminative stimulus effects in rats. Neuropharmacology, 2007, 53, 481–486.

    Article  CAS  Google Scholar 

  23. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ: Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharmacology, 2005, 179, 551–558.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Chodźki 4a, PL 20-093, Lublin, Poland

    Joanna Listos, Alicja Merska & Sylwia Fidecka

Authors
  1. Joanna Listos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alicja Merska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sylwia Fidecka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Listos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Listos, J., Merska, A. & Fidecka, S. Pharmacological activity of Salvinorin A, the major component of Salvia divinorum. Pharmacol. Rep 63, 1305–1309 (2011). https://doi.org/10.1016/S1734-1140(11)70694-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1734-1140(11)70694-6

Key words

Search

Navigation